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Background. Serial transverse enteroplasty facilitates weaning from parenteral support in selected
patients with short bowel syndrome, although repeated procedure is frequently required. Our aim was to
evaluate the outcome of a series of patients after serial transverse enteroplasty and define predictors of
repeated serial transverse enteroplasty and weaning off parenteral support.
Methods. All children who underwent serial transverse enteroplasty at 4 Nordic pediatric surgery centers
from 2004–2015 were included in this observational study. Data were collected from the patient records.
The study was approved by the local ethics review boards.
Results. Twenty-seven children with short bowel with initial median small bowel length of 26 cm (range,
10–100 cm) were included. Eleven patients had the ileocecal valve remaining. Serial transverse
enteroplasty was performed at median age of 7.5 months (range, 0.9–224 months). Serial transverse
enteroplasty made the small bowel 46% (0–233%) longer. Eleven patients (41%) underwent a repeated
serial transverse enteroplasty 12 months (1.0–72 months) later; 7 patients required additional operative
procedures, but none were transplanted. At follow-up, 45.1 months (1.8–126 months) after the first
serial transverse enteroplasty, 11 (41%) patients needed parenteral support. The remaining 16 patients
had been weaned off parenteral support. One patient had died. Absence of the ileocecal valve was the
only factor, which predicted the need for a repeated serial transverse enteroplasty (odds ratio 16.7, 95%
confidence interval, 1.7–164.8, P = .007). No factor was identified predicting need for parenteral
support at follow-up.
Conclusion. A majority of children with short bowel syndrome can be weaned from parenteral support
after serial transverse enteroplasty. The absence of the ileocecal valve predicts the need for a repeated
serial transverse enteroplasty, which was required by 40% of the patients. (Surgery 2017;161:818-22.)From the Unit of Pediatric Surgery,a Department of Women’s and Children’s Health, Karolinska University
Hospital, and Karolinska Institutet, Stockholm; Unit of Pediatric Surgery,b Department of Women’s and
Children’s Health, University Children’s Hospital, Uppsala; Department of Pediatric Surgery,c Skane
University Hospital, Lund, Sweden; and Pediatric Surgery,d Pediatric Liver and Gut Research Group,
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URGERYintestinal failure. The main causes of neonatal
short bowel are necrotizing enterocolitis, intestinal
atresia, gastroschisis, and malrotation with
volvulus.1,2 Adaptation-associated bowel dilatation
often presents with increasing feeding intolerance,
which precludes weaning from parenteral support.
This, in addition to symptoms of intestinal bacterial
overgrowth and dysmotility such as diarrhea, vomit-
ing, and/or D-lactic acidosis, is an indication to
consider operative management.3,4 Autologous in-
testinal reconstruction by a longitudinal intestinal
lengthening and tapering procedure was first
described by Bianchi et al5 in 1980. More recently,
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less challenging procedure, was introduced in
2003.6,7 STEP has been shown to facilitate weaning
from parenteral support in selected patients with
short bowel syndrome, although repeated proced-
ure is frequently required.8 Factors that predict
the need for repeated STEP and weaning off paren-
teral support have not been well characterized.
The aim of this study was to evaluate the
outcomes of a series of patients after STEP and
define predictors of repeated STEP and need for
parenteral support at follow-up.
METHODS
This cross-sectional, observational study was
approved by the local ethics review boards. After
informed consent was provided, all children who
underwent STEP at 4 Nordic pediatric surgery
centers from 2004–2015 were included. Data were
collected retrospectively from the patient records.
The recorded variables were sex, gestational age,
birth weight, birth height, cause of short bowel,
initial small bowel length, absence of the ileocecal
valve, and number of laparotomies before STEP.
Data on indication for STEP and repeated STEP,
weight and height before STEP, total small bowel
length before and after the reconstruction,
maximal bowel width at STEP and repeated
STEP, and number of stapler firings also were
collected. Number of parenteral support infusions
and the ratio of enteral/total caloric intake before
STEP and at follow-up were registered. The date
when full enteral autonomy was achieved was
recorded. Z scores for weight and height as well
as serum bilirubin and liver enzyme levels before
STEP and at follow-up were compared. Sex,
gestational age, cause of short bowel, initial small
bowel length, and absence of ileocecal valve were
analyzed as potential predictive risk factors for the
need for repeated STEP. The ability of sex,
gestational age, cause of short bowel, initial small
bowel length, and absence of ileocecal valve, in
addition to repeated STEP, to predict need for
parenteral support at follow-up was analyzed.
Statistics. Categorical data are presented as
frequencies and continuous data as median
(range). For potential predictive factors, odds
ratios with 95% confidence intervals were calcu-
lated, and Fisher exact test was used for further
analysis. Data on gestational age (#34 weeks;
>34 weeks) and initial small bowel length
(#30 cm; >30 cm) were categorized. The sample
size and the number of events were considered too
small for multivariable analysis. Wilcoxon signed-
rank test was used to compare bowel length beforeand after STEP as well as levels of bilirubin and
liver enzymes, z scores for weight and height, and
enteral tolerance before STEP and at follow-up.
Statistical analysis was carried out with SPSS
version 22.0 software (IBM, Armonk, NY).
RESULTS
Twenty-seven children with short bowel, 13 girls
and 14 boys, who underwent 39 STEP procedures
were included. The median gestational age was
34 weeks (23–40 weeks). The median birth weight
was 2,356 g (4953,900 g), and birth height was
45 cm (28–54 cm). The cause of short bowel was
small bowel atresia (n = 18), volvulus (n = 6), gastro-
schisis (n = 7), and necrotizing enterocolitis (n = 4).
In some cases>1 underlying condition was encoun-
tered. The initial median small bowel length was
26 cm (10–100 cm). The patients had undergone
2 (1–10) laparotomies before STEP. All patients de-
pended on parenteral support before STEP. The
median number of weekly parenteral support infu-
sions was 7 (2–7). The median ratio of enteral/total
caloric intake was 0.24 (0–0.84). Before STEP 17 pa-
tients had symptoms of bacterial overgrowth, 14 had
culture-verified septicemia, 16 were dependent on
enteral antibiotics, and 15 had fluid and electrolyte
disturbances.
STEP. The indication for STEP was adaptation-
associated bowel dilatation in combination with
symptoms and findings shown in Table I. STEP was
performed as previously described2,8 at median
age of 7.5 months (0.9–224 months). The median
body weight at STEP was 6.5 kg (3.7–34.0 kg), and
height was 63 cm (52–163 cm). Eleven patients
(41%) had the ileocecal valve remaining. The me-
dian total small bowel length before STEP was
54 cm (15–93 cm), and themedian total small bowel
length after STEP was 71 cm (27–150 cm; P< .001).
Themedianmaximal small bowel width was 5 cm.2-8
A median number of 9 stapler firings (2–25) were
used for the reconstruction. STEP made the small
bowel 46% (0–233%) longer. At the time of STEP
3 patients underwent an additional segmental
tapering enteroplasty, 3 underwent strictureplasty,
2 bowel resections, and 8 underwent other addi-
tional procedures (significant adhesiolysis, gastro-
stomy, revision of anastomosis, or stoma closure).
Early complications included bleeding (n = 1),
leakage (n = 1), fascia rupture (n = 2), throm-
bosis/endocarditis (n = 1), and septicemia (n = 1).
Repeated STEP. Eleven patients (41%) under-
went repeat STEP 12 months (1.0–72 months)
after initial STEP. The indication for repeat STEP
was symptoms and findings shown in Table I. Six
patients (54%) who underwent repeated STEP
Table I. Indications for initial STEP and repeat
STEP
Initial
STEP
(n = 27)
Repeat
STEP
(n = 11)
Inability to increase
enteral intake
25 8
Dysmotility 21 7
Vomiting 17 5
Bacterial overgrowth 15 8
Fluid and electrolyte
problems
13 4
Obstructive symptoms 9 3
Increased secretions 5 5
Intestinal failure-associated
liver disease
3 0
D-lactic acidosis 3 2
Vascular access problems 0 1
Redilatation Not applicable 7
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weight before repeated STEP was 11.4 kg
(6.5–33.0 kg) and median height was 83 cm
(60–163 cm). The median total small bowel length
before repeated STEP was 90 cm (54–150 cm) and
after the reconstruction 101 cm (60–180 cm;
P = .005). A median of 12 stapler firings (2–22)
were used. Three patients underwent concomitant
segmental tapering enteroplasty and one under-
went strictureplasty. There were no early complica-
tions after repeat STEP.
Additional procedures. Seven patients required
further operative procedures: small bowel resec-
tion (n = 2), tapering (n = 2), gastrostomy (n = 1),
and a third STEP (n = 1). No patient needed small
bowel transplantation. One of the patients under-
went a limited small bowel resection twice due to
chronic small bowel ulcers causing iron-
deficiency anemia and hypoalbuminemia.
Outcomes. At follow-up, 45.1 months (1.8–
126.0 months) after the first STEP and 12.8 months
(1.8–80.0 months) after repeated STEP, 11 (41%)
patients required parenteral support. The remain-
ing 16 (59%) patients had been completely weaned
from parenteral support 16.5 months after first
STEP (0.7–109.2). Six (55%) of 11 patients who
had undergone repeated STEP had been weaned
from parenteral support compared with 10 (62%)
of 16 patients who had only undergone one STEP
(P = .710). Three of 7 patients who had small bowel
redilatation when they underwent repeated STEP
had been weaned off parenteral support. The 11
patients on parenteral support at follow-up needed
7 parenteral infusions per week (3.5–7 weeks) and
the median enteral caloric intake/total caloricintake ratio was 0.63 (0.42–0.90) compared with
0.27 (0.06–0.83) before STEP (P = .004). The me-
dian z score for weight before STEP was 1.24
(4.98 to 0.71) and at follow-up 0.89 (4.08 to
1.15; P = 1.00). The median z score for height
before STEP was 1.18 (6.23 to 0.78) and at
follow-up 1.11 (3.65 to 1.34; P = .29). Seven pa-
tients depended on continuous enteral antibiotics,
6 had had culture-verified septicemia, 7 had symp-
toms indicating bacterial overgrowth, 3 were vomit-
ing, and 5 had diarrhea causing electrolyte
disturbances. In 5 patients redilatation of the small
bowel was observed, 3 of who had undergone a
repeated STEP. One patient had died due to an
Abernethy malformation and septicemia.
Bilirubin and liver enzyme levels before STEP
and at follow-up are shown in Table II. Six patients
had total bilirubin >20 mmol/L before STEP
compared with 1 at follow-up.
Predictive factors needed for repeated STEP.
The analysis of potential predictive factors for
repeated STEP is shown in Table III. Absence of
the ileocecal valve was the only factor that pre-
dicted the need for a repeated STEP (odds ratio
16.7, 95% confidence interval, 1.7–164.8, P = .007).
Predictive factors for enteral autonomy at
follow-up. The analysis of potential predictive
factors for need for parenteral nutrition at
follow-up is shown in Table IV. No risk factor could
be identified predicting need for parenteral sup-
port at follow-up.
DISCUSSION
This series of 27 children with short bowel and
intestinal failure managed with STEP at 4 Nordic
pediatric surgery centers is one of the largest in the
literature. Most previous studies originate from
major North American centers. In the present study
repeated STEP was required by 41% of the patients,
while 59% of the patients had been weaned off
parenteral support by amedian time of 16.5months
after STEP. Among the patients who remained
dependent onparenteral support after STEP, paren-
teral energy requirement reduced significantly. It
has been reported that 33–88% of patients can be
weaned off parenteral support after STEP.4,8-15 The
patients who had undergone repeated STEP had a
similar chance to be weaned off parenteral support
comparedwith thosewhounderwentonly one STEP
supporting active operative approach to redilata-
tion. There were no significant differences between
weight and height z scores before STEP and at
follow-up. Javid et al14 showed that weight-for-age z
score had increased at follow-up, whereas height-
for-age z score did not change significantly. Mercer
Table II. Total bilirubin, conjugated bilirubin, ASAT, and ALAT before STEP and at follow-up
Before STEP At follow-up P value*
Total bilirubin, mmol/L 8.5 (2–242) 4 (2–26) .017
Conjugated bilirubin, mmol/L 3.95 (1–185) 2 (2–8) .064
ASAT, mkat/L 0.85 (0.37–10.0) 0.60 (0.40–4.02) .115
ALAT, mkat/L 0.665 (0.19–3.4) 0.47 (0.28–3.06) .527
*Wilcoxon signed-rank test.
ASAT, Aspartate aminotransferase; ALAT, alanine aminotransferase.
Table III. Predictive factors for the need of
repeated STEP
Predictive factor n OR (95% CI) P value*
Sex
Male 6/11 1.20 (0.26–5.59) 1.00
Female 5/11 1
Gestational age
#34 wk 8/11 2.67 (0.51–13.88) .43
>34 wk 3/11 1
Cause of short bowel
Bowel atresia 7/11 0.80 (0.16–4.02) 1.00
Volvulus 2/11 0.67 (0.10–4.48) 1.00
Gastroschisis 5/11 5.83 (0.87–38.9) .084
NEC 2/11 1.56 (0.18–13.11) 1.00
Initial small bowel length
#30 cm 7/11 0.58 (0.11–3.10) .68
>30 cm 4/11 1
Absent ileocecal valve
Yes 10/11 16.67 (1.69–164.8) .008
No 1/11 1
*Fisher exact test.
In total, 11 patients underwent repeated STEP. Odds ratio with 95% con-
fidence interval (CI) was calculated.
NEC, Necrotizing enterocolitis.
Table IV. Predictive factors for parenteral support
at follow-up
Predictive factor n OR P value*
Sex
Male 6/11 1.20 (0.26–5.59) 1.00
Female 5/11 1
Gestational age
#34 wk 8/11 2.67 (0.51–13.88) .43
>34 wk 3/11 1
Cause of short bowel
Bowel atresia 6/11 0.40 (0.08–2.06) .41
Volvulus 2/11 0.67 (0.10–4.48) 1.00
Gastroschisis 3/11 1.12 (0.20–6.43) 1.00
NEC 3/11 5.62 (0.50–63.28) .27
Initial small bowel length
#30 cm 9/11 2.70 (0.43–16.94) .40
>30 cm 2/11 1
Absent ileocecal
valve
8/11 2.67 (0.51–13.88) .43
Ileocecal valve 3/11 1
Repeated STEP
Yes 5/11 1.39 (0.29–6.61) .71
No 6/11 1
*Fisher exact test.
Odds ratio (OR) with 95% confidence interval was calculated.
NEC, Necrotizing enterocolitis; STEP, serial transverse enteroplasty.
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ally increased during the first year after STEP. The
increase in z score for weight became statistically sig-
nificant 1 year after STEP. In the present study, oper-
ative and early postoperative complications were
few, as expected from previous reports.4 Also, liver
enzymes and bilirubin had improved at follow-up
compared with before STEP. Mortality was low, and
the death in this series was not related to the STEP
procedure.
One aim of this study was to define predictive
factors of the need for repeated STEP and need
for parenteral nutrition at follow-up. We choose to
analyze whether sex, gestational age, cause of short
bowel, initial small bowel length, and absent
ileocecal valve could predict the need for repeated
STEP. Absent ileocecal valve was the only factor
that predicted the need for repeated STEP. The
ileocecal region is the sole source of various
enterohormones regulating intestinal motility,
growth, and absorptive function with uniquefunctional properties, which may explain this
finding. Although redilatation represents one of
the main complications of STEP occurring in 30–
40% of the patients, predictive factors for repeated
STEP have not been well characterized previously.
Most previous studies have focused on feasibility
and enteral autonomy. We also analyzed if sex,
gestational age, cause of short bowel, initial small
bowel length, absent ileocecal valve, and repeated
STEP predicted need for parenteral support at
follow-up. None of these factors predicted need for
parenteral support. It has been shown previously,
in a large cohort of children with intestinal failure,
that longer bowel length, preserved ileocecal valve,
and underlying NEC was associated with weaning
off parenteral support.16 It was shown recently that
excessive small bowel dilatation in contrast series,
both measured as absolute terms and as ratio be-
tween maximal small bowel width and the height
Surgery
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from parenteral support as well as survival.17 Previ-
ous data indicate that children who experience re-
dilatation after STEP had worse prognosis and
were less likely to be weaned off parenteral nutri-
tion.18,19 We could not analyze small bowel diam-
eter ratio systematically in this group of patients
as contrast studies had not been performed
routinely in all children. It is interesting that
absence of the ileocecal valve predicted the need
for repeat STEP, but not ultimately the ability to
wean off parenteral support. This difference could
be explained by the small sample size. It also is
possible that parameters not analyzed in this study,
such as remaining length of ileum, colonic length,
and small bowel diameter, are important.
The 2 main limitations of this study were the lack
of controls and a relatively small sample size. Ideally,
a randomized, controlled trial comparing serial
transverse enteroplasty with conservative treatment
would be undertaken. This would make it easier to
define indications for STEP and also ascertain long-
term effects. However, such a trial would be
ethically very difficult to undertake. Pakarinen
et al13 showed retrospectively that children with
short bowel syndrome had similar mortality rate
and parenteral support dependency at 4 years
with or without an autologous intestinal reconstruc-
tion. The small sample size in our study makes it
likely that type 2 errors could influence the analysis
of predictive factors. Also, the low number of
events, repeated STEP, and weaning off parenteral
support was too low for multivariable analysis, which
would have been preferable. Another limitation of
the study was that there were no predetermined
clinical set of circumstances that would lead to
repeat STEP. The decision to repeat STEP was
made by the individual surgeon.
In conclusion, a majority of children with short
bowel syndrome can be weaned off parenteral
support after STEP. The absence of the ileocecal
valve predicts the need for repeated STEP, which
was required by 41% of the patients. Whenever
possible, the ileocecal valve should be preserved.
However, this is often not an option because the
ileocecal valve is absent at birth or the bowel is
virtually necrotic and resection unavoidable. Chan-
ces for weaning off parenteral support and survival
were similar after the first and repeated STEP.REFERENCES
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